144 related articles for article (PubMed ID: 20545593)
1. The economics of improved cancer survival rates: better outcomes, higher costs.
Uyl-de Groot CA; de Groot S; Steenhoek A
Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):283-92. PubMed ID: 20545593
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
3. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
4. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
Inadomi JM
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
[TBL] [Abstract][Full Text] [Related]
5. Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs.
Evans WK; Nefsky M; Pater J; Browman G; Cowan DH
Chronic Dis Can; 2002; 23(4):152-6. PubMed ID: 12517323
[TBL] [Abstract][Full Text] [Related]
6. Association of insurance with cancer care utilization and outcomes.
Ward E; Halpern M; Schrag N; Cokkinides V; DeSantis C; Bandi P; Siegel R; Stewart A; Jemal A
CA Cancer J Clin; 2008; 58(1):9-31. PubMed ID: 18096863
[TBL] [Abstract][Full Text] [Related]
7. The cost of cancer.
Cromwell J; Gertman P
Laryngoscope; 1979 Mar; 89(3):393-409. PubMed ID: 107379
[TBL] [Abstract][Full Text] [Related]
8. Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector?
Keating NL; Landrum MB; Meara E; Ganz PA; Guadagnoli E
J Natl Cancer Inst; 2005 Feb; 97(4):257-64. PubMed ID: 15713960
[TBL] [Abstract][Full Text] [Related]
9. Outpatient cancer drug costs: changes, drivers, and the future.
Halbert RJ; Zaher C; Wade S; Malin J; Lawless GD; Dubois RW
Cancer; 2002 Feb; 94(4):1142-50. PubMed ID: 11920485
[TBL] [Abstract][Full Text] [Related]
10. Risks of online direct-to-consumer tumor markers for cancer screening.
Lovett KM; Liang BA; Mackey TK
J Clin Oncol; 2012 May; 30(13):1411-4. PubMed ID: 22355060
[No Abstract] [Full Text] [Related]
11. Innovative cancer therapies: putting costs into context.
Khayat D
Cancer; 2012 May; 118(9):2367-71. PubMed ID: 21918962
[TBL] [Abstract][Full Text] [Related]
12. Era of personalized medicine may herald end of soaring cancer costs.
Keogh B
J Natl Cancer Inst; 2012 Jan; 104(1):12-3, 16-7. PubMed ID: 22173586
[No Abstract] [Full Text] [Related]
13. [Health care expenditures linked to the use of targeted therapies and diagnostic tests for cancer patients].
Marino P; Bertucci F; Gonçalves A; Seror V
Med Sci (Paris); 2012 Mar; 28 Spec No 1():19-23. PubMed ID: 22494652
[TBL] [Abstract][Full Text] [Related]
14. [The cost of chemotherapy].
Lévy C; Bonastre J
Bull Cancer; 2003 Nov; 90(11):976-82. PubMed ID: 14706901
[TBL] [Abstract][Full Text] [Related]
15. Valuing end-of-life care in the United States: the case of new cancer drugs.
Sorenson C
Health Econ Policy Law; 2012 Oct; 7(4):411-30. PubMed ID: 23079300
[TBL] [Abstract][Full Text] [Related]
16. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
17. [Cost of medications in the oncology sector in the context of health economics].
Walter E; Batista A
Wien Med Wochenschr; 2008; 158(7-8):227-33. PubMed ID: 18500477
[TBL] [Abstract][Full Text] [Related]
18. Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen.
Krahn MD; Coombs A; Levy IG
CMAJ; 1999 Jan; 160(1):49-57. PubMed ID: 9934343
[TBL] [Abstract][Full Text] [Related]
19. Costs of cancer care: a view from the centers for Medicare and Medicaid services.
Bach PB
J Clin Oncol; 2007 Jan; 25(2):187-90. PubMed ID: 17210938
[TBL] [Abstract][Full Text] [Related]
20. Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Herbst RS; Bajorin DF; Bleiberg H; Blum D; Hao D; Johnson BE; Ozols RF; Demetri GD; Ganz PA; Kris MG; Levin B; Markman M; Raghavan D; Reaman GH; Sawaya R; Schuchter LM; Sweetenham JW; Vahdat LT; Vokes EE; Winn RJ; Mayer RJ;
J Clin Oncol; 2006 Jan; 24(1):190-205. PubMed ID: 16326753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
